KEGG enrichment analysis demonstrated that the most important pathways of arctigenin metabolites for AD treatment were MAPK, Neurotrophin, Calcium, cAMP, neurodegeneration-multiple diseases, and FoxO signalling pathways. Here, BDNF is linked to Alzheimer disease.